BackAura Biosciences Overview

Aura Biosciences Long Term Debt

Aura Biosciences's long-term debt is $14M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$13.72M
↓ 10.14% YoYΔ $-1.55M vs prior year quarter

Peer average

Loading

Aura Biosciences Long Term Debt History

Loading

Aura Biosciences vs. peers: Long Term Debt Comparison

Loading

Aura Biosciences Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Aura Biosciences (AURA) FAQ

As of the most recent data (March 2026), AURA shows a long-term debt of $14M. That compares with $15M in the prior-year period — down 10.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AURA's long-term debt is now $14M (was $15M) — a 10.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Aura Biosciences is outperforming or lagging.

Tracking AURA's long-term debt over time shows whether Aura Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $14M That compares with $15M in the prior-year period — down 10.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Aura Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $14M) with ownership activity and broader fundamentals.